IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL

IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL

Human glioblastoma is the most aggressive human primary brain tumor and is currently incurable. Immunitherapies have the pontential to target glioma and glioma stem cells (GSCs) that are resistant to conventional thepies. We previously identified and characterized two mutually exclusive GSC subtypes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2014-11, Vol.16 (Suppl 5), p.v112-v112
Hauptverfasser: Iwata, Ryoichi, Asai, Akio, Oshige, Hideyuki, Yoshimura, Kunikazu, Nonaka, Masahiro, Nakano, Ichiro
Format: Artikel
Sprache:eng
Schlagworte:
Abstracts
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page v112
container_issue Suppl 5
container_start_page v112
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 16
creator Iwata, Ryoichi
Asai, Akio
Oshige, Hideyuki
Yoshimura, Kunikazu
Nonaka, Masahiro
Nakano, Ichiro
description Human glioblastoma is the most aggressive human primary brain tumor and is currently incurable. Immunitherapies have the pontential to target glioma and glioma stem cells (GSCs) that are resistant to conventional thepies. We previously identified and characterized two mutually exclusive GSC subtypes with distinct dysregulated signaling pathways. Analysis of mRNA profiles distinguished proneural (PN) from mesenchymal (Mes) GSCs and revealed a pronounced correlation with the corresponding PN or Mes HGGs. Here we show the expression of Inducible costimulator-ligand (ICOSL) by glioma cells in vitro and in vivo. We identified that Mes GSCs specificaly expressd ICOSL, however, PN GSCs did not express it. Further, immunohistochemical analysis of human brain tumors demonstrates the expression of ICOSL around the vessels. ICOSL is a member of the B7 family of costimulatory molecules related to CD80/CD86, regulates CD4 as well as CD8 T-cell responses via interaction with its receptor, ICOS, on activated T cells. ICOSL could be a novel target for immunotherapy.
doi_str_mv 10.1093/neuonc/nou258.12
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4218230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4218230</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_42182303</originalsourceid><addsrcrecordid>eNqljE8LgjAcQEcUZH_uHfcFzP2mM7sEIquEmdE81GmYWRk1QzPo2wfRpXOn9-DBQ2gEZAxkals6b0qdWbpsKPPGQFvIAEZtk3mu2_44NT0Gky7q1fWFEArMBQNZYWKCE3HJV8FyF_kCL0QYRz6WCY9wwIXAfLvecClxGMRSDFDnmF7rfPhlH83mPAmW5r3Z3_JDlutHlV7VvSpuafVSZVqo36KLszqVT-VQ8KhN7L8Hb7WiTQk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Iwata, Ryoichi ; Asai, Akio ; Oshige, Hideyuki ; Yoshimura, Kunikazu ; Nonaka, Masahiro ; Nakano, Ichiro</creator><creatorcontrib>Iwata, Ryoichi ; Asai, Akio ; Oshige, Hideyuki ; Yoshimura, Kunikazu ; Nonaka, Masahiro ; Nakano, Ichiro</creatorcontrib><description>Human glioblastoma is the most aggressive human primary brain tumor and is currently incurable. Immunitherapies have the pontential to target glioma and glioma stem cells (GSCs) that are resistant to conventional thepies. We previously identified and characterized two mutually exclusive GSC subtypes with distinct dysregulated signaling pathways. Analysis of mRNA profiles distinguished proneural (PN) from mesenchymal (Mes) GSCs and revealed a pronounced correlation with the corresponding PN or Mes HGGs. Here we show the expression of Inducible costimulator-ligand (ICOSL) by glioma cells in vitro and in vivo. We identified that Mes GSCs specificaly expressd ICOSL, however, PN GSCs did not express it. Further, immunohistochemical analysis of human brain tumors demonstrates the expression of ICOSL around the vessels. ICOSL is a member of the B7 family of costimulatory molecules related to CD80/CD86, regulates CD4 as well as CD8 T-cell responses via interaction with its receptor, ICOS, on activated T cells. ICOSL could be a novel target for immunotherapy.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/nou258.12</identifier><language>eng</language><publisher>Oxford University Press</publisher><subject>Abstracts</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v112-v112</ispartof><rights>Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2014. 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218230/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218230/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Iwata, Ryoichi</creatorcontrib><creatorcontrib>Asai, Akio</creatorcontrib><creatorcontrib>Oshige, Hideyuki</creatorcontrib><creatorcontrib>Yoshimura, Kunikazu</creatorcontrib><creatorcontrib>Nonaka, Masahiro</creatorcontrib><creatorcontrib>Nakano, Ichiro</creatorcontrib><title>IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL</title><title>Neuro-oncology (Charlottesville, Va.)</title><description>Human glioblastoma is the most aggressive human primary brain tumor and is currently incurable. Immunitherapies have the pontential to target glioma and glioma stem cells (GSCs) that are resistant to conventional thepies. We previously identified and characterized two mutually exclusive GSC subtypes with distinct dysregulated signaling pathways. Analysis of mRNA profiles distinguished proneural (PN) from mesenchymal (Mes) GSCs and revealed a pronounced correlation with the corresponding PN or Mes HGGs. Here we show the expression of Inducible costimulator-ligand (ICOSL) by glioma cells in vitro and in vivo. We identified that Mes GSCs specificaly expressd ICOSL, however, PN GSCs did not express it. Further, immunohistochemical analysis of human brain tumors demonstrates the expression of ICOSL around the vessels. ICOSL is a member of the B7 family of costimulatory molecules related to CD80/CD86, regulates CD4 as well as CD8 T-cell responses via interaction with its receptor, ICOS, on activated T cells. ICOSL could be a novel target for immunotherapy.</description><subject>Abstracts</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqljE8LgjAcQEcUZH_uHfcFzP2mM7sEIquEmdE81GmYWRk1QzPo2wfRpXOn9-DBQ2gEZAxkals6b0qdWbpsKPPGQFvIAEZtk3mu2_44NT0Gky7q1fWFEArMBQNZYWKCE3HJV8FyF_kCL0QYRz6WCY9wwIXAfLvecClxGMRSDFDnmF7rfPhlH83mPAmW5r3Z3_JDlutHlV7VvSpuafVSZVqo36KLszqVT-VQ8KhN7L8Hb7WiTQk</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Iwata, Ryoichi</creator><creator>Asai, Akio</creator><creator>Oshige, Hideyuki</creator><creator>Yoshimura, Kunikazu</creator><creator>Nonaka, Masahiro</creator><creator>Nakano, Ichiro</creator><general>Oxford University Press</general><scope>5PM</scope></search><sort><creationdate>20141101</creationdate><title>IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL</title><author>Iwata, Ryoichi ; Asai, Akio ; Oshige, Hideyuki ; Yoshimura, Kunikazu ; Nonaka, Masahiro ; Nakano, Ichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_42182303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwata, Ryoichi</creatorcontrib><creatorcontrib>Asai, Akio</creatorcontrib><creatorcontrib>Oshige, Hideyuki</creatorcontrib><creatorcontrib>Yoshimura, Kunikazu</creatorcontrib><creatorcontrib>Nonaka, Masahiro</creatorcontrib><creatorcontrib>Nakano, Ichiro</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwata, Ryoichi</au><au>Asai, Akio</au><au>Oshige, Hideyuki</au><au>Yoshimura, Kunikazu</au><au>Nonaka, Masahiro</au><au>Nakano, Ichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2014-11-01</date><risdate>2014</risdate><volume>16</volume><issue>Suppl 5</issue><spage>v112</spage><epage>v112</epage><pages>v112-v112</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>Human glioblastoma is the most aggressive human primary brain tumor and is currently incurable. Immunitherapies have the pontential to target glioma and glioma stem cells (GSCs) that are resistant to conventional thepies. We previously identified and characterized two mutually exclusive GSC subtypes with distinct dysregulated signaling pathways. Analysis of mRNA profiles distinguished proneural (PN) from mesenchymal (Mes) GSCs and revealed a pronounced correlation with the corresponding PN or Mes HGGs. Here we show the expression of Inducible costimulator-ligand (ICOSL) by glioma cells in vitro and in vivo. We identified that Mes GSCs specificaly expressd ICOSL, however, PN GSCs did not express it. Further, immunohistochemical analysis of human brain tumors demonstrates the expression of ICOSL around the vessels. ICOSL is a member of the B7 family of costimulatory molecules related to CD80/CD86, regulates CD4 as well as CD8 T-cell responses via interaction with its receptor, ICOS, on activated T cells. ICOSL could be a novel target for immunotherapy.</abstract><pub>Oxford University Press</pub><doi>10.1093/neuonc/nou258.12</doi></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v112-v112
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4218230
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Abstracts
title IT-14MESENCHYMAL GLIOMA STEM CELL EXPRESS ICOSL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T11%3A25%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IT-14MESENCHYMAL%20GLIOMA%20STEM%20CELL%20EXPRESS%20ICOSL&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Iwata,%20Ryoichi&rft.date=2014-11-01&rft.volume=16&rft.issue=Suppl%205&rft.spage=v112&rft.epage=v112&rft.pages=v112-v112&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/nou258.12&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4218230%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true